Financials in USD. Standardized financial statements.
A compact view of how Justera Health Ltd. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|
| Revenue? | $1.42M | $1.91M | $14.69M | $21.39M | $0 | $0 | $0 |
| Revenue Growth? | -25.8% | -87.0% | -31.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $527,507 | $1.06M | $12.11M | $21.71M | $0 | $0 | $0 |
| Gross Profit? | $892,976 | $856,574 | $2.58M | -$324,032 | $0 | $0 | $0 |
| Gross Margin? | +62.9% | +44.8% | +17.6% | -1.5% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $3.34M | $4.69M | $6.50M | $3.56M | $72,332 | $52,429 | $104,667.22 |
| Operating Income? | -$2.45M | -$3.83M | -$3.92M | -$3.21M | $0 | $0 | -$104,667.22 |
| EBITDA? | -$2.31M | -$3.43M | -$2.81M | -$3.24M | -$72,332 | -$52,429 | -$104,667.22 |
| Income Before Tax | -$3.74M | -$3.02M | -$5.25M | -$9.38M | -$72,332 | -$52,429 | -$104,667.22 |
| Income Tax Expense | $0 | -$40,022 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$4.21M | -$2.98M | -$5.25M | -$9.38M | -$72,332 | -$52,429 | -$104,667.22 |
| EPS? | $-0.02 | $-0.02 | $-0.06 | $-0.24 | $-0.01 | $-0.01 | $-0.22 |
| Diluted EPS? | $-0.02 | $-0.02 | $-0.06 | $-0.24 | $-0.01 | $-0.01 | $-0.22 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality